I-TFF Pharmaceuticals izobamba intlanganiso yezemali kwi-Q2 2022

FORT WORTH, TX, Agasti 2, 2022 (i-GLOBE NEWSWIRE) - i-TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) yinkampani yezonyango ye-biopharmaceutical yenqanaba lezonyango egxile kwi-Thin Film Refrigeration (TFF) iqonga letekhnoloji yophuhliso kunye norhwebo lweemveliso zamayeza ezitsha. , namhlanje ibhengeze ukuba iya kukhupha iziphumo zayo zekota yesibini ye-2022 yezemali kunye nokuphononongwa kweshishini ngoLwesine.Nge-11 ka-Agasti, ngo-2022, ekupheleni kweemarike zemali zase-US.
Abaphathi baya kubamba inkomfa yenkomfa ngo-4: 30 pm ET ukuxoxa ngeziphumo zemali kunye nokubonelela ngohlaziyo malunga nophuhliso lwenkampani kunye neklinikhi.Inkcazo-ntetho iya kulandelwa yiseshoni ye-Q&A kunye nabatyali-mali.
Inkampani iya kubamba umnxeba wenkomfa ngoLwesine, Agasti 11, 2022 ngo-4: 30 pm ET ukuphonononga ukusebenza kweklinikhi, ushishino kunye nemali.Ukujoyina inkomfa, joyina i-webcast okanye ucofe enye yezi zilandelayo phambi kokuba uqalise umnxeba:
Umnxeba uya kubhengezwa ngqo kwiwebhu kwaye unokufumaneka kwiwebhusayithi ye-TFF Pharmaceuticals', https://tffpharma.com okanye ngqo ku-https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Umnxeba uya kubhengezwa ngqo kwiwebhu kwaye unokufumaneka kwiwebhusayithi ye-TFF Pharmaceuticals', https://tffpharma.com okanye ngqo ku-https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Конференция также будет транслироваться в прямом эфире и доступна на веб-сайте TFF Pharmaceuticals https://tffpharma.com или непосредственноeb на прямом эфире и доступна на веб-сайте TFF Pharmaceuticals https://tffpharma.com или непосредственноeb на прямом эфире и доступна на веб-сайте TFF Pharmaceutics tp_key=43b9453c47. Inkomfa iya kusasazwa ngqo kwaye ifumaneke kwiwebhusayithi ye-TFF Pharmaceuticals https://tffpharma.com okanye ngqo https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47.电话会议还将进行网络直播,可以在TFF Pharmaceuticals的网站https://tffpharma.com 或直接访问https://viavid.webcasts.com/starti1=3_3c3p9&jsp? 7 访问. TFF Pharmaceuticals 的网站https://tffpharma.com 或直接访问https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key34=43 Конференц-связь также будет транслироваться в Интернете и доступна на веб-сайте I-TFF Pharmaceuticals ifumaneka kwi-https://tffpharma.com или напрямspупер/ukuqala apha. i=1558913&tp_key=43b9453c47. Umnxeba wenkomfa uya kubhengezwa kwiwebhu kwaye uyafumaneka kwiwebhusayithi ye-TFF Pharmaceuticals ku-https://tffpharma.com okanye ngqo ku-https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47.Nceda undwendwele iwebhusayithi yenkampani ubuncinci kwimizuzu eli-15 ngaphambi kokuba ubhalise, ukhuphele kwaye ufake yonke isoftware yeaudio efunekayo.Umnxeba uya kudlalwa inyanga yonke kwicandelo leKhalenda yabatyali-mali kwiwebhusayithi yenkampani.
Malunga neTFF PHARMACEUTICALS Thin Film Freezing Technology Platform TFF Pharmaceuticals' patented Thin Film Freezing (TFF) ubuchwepheshe buvumela iikhompawundi ezikhoyo kunye neekhemikhali ezintsha ukuba ziguqulwe zibe yimixube eyomileyo yomgubo eneempawu ezizodwa kunye neenzuzo.Inkqubo yokukhenkcisa ifilimu yinkqubo yobunjineli besuntswana eyenzelwe ukuvelisa amasuntswana omgubo omileyo aneempawu ezifanelekileyo zokuphefumla, i-parenteral, impumlo, i-oral, i-topical kunye ne-ophthalmic iindlela zokulawula.Le nkqubo ingasetyenziselwa ukuphuhlisa iipowder ukuhanjiswa ngokuthe ngqo kwindawo efunwayo, ngaloo ndlela igwema iingxaki zolawulo lwenkqubo kunye nokuphucula i-bioavailability, ukuqala ngokukhawuleza kwesenzo, kunye nokuphucula ukhuseleko kunye nokusebenza kakuhle.Ukukwazi ukuhambisa unyango ngokuthe ngqo kwizitho ezijoliswe kuzo ezifana nemiphunga ivumela i-TFF powder ukuba ilawulwe ngamaxabiso aphantsi xa kuthelekiswa nokuqulunqwa komlomo, ukunciphisa ubuthi obungadingekile kunye nemiphumo emibi.Idatha yelabhoratri ibonisa ukuba iimpawu ze-aerodynamic zefilimu ebhityileyo engumgubo ekhenkcezisiweyo inokuhambisa ukuya kuma-75% ethamo nzulu emiphungeni.Esikhundleni sokuvezwa kubushushu, uxinzelelo lwe-chear, okanye ezinye izinto ezinokonakalisa amacandelo onyango antsonkothileyo anje ngebhayoloji ebuthathaka, ukukhenkceza kwefilimu encinci kuvumela ukuba ezi zixhobo ziguqulwe zibe ngumgubo owomileyo ekulula ukuwugcina kunye nobushushu obuzinzileyo, okuvumela unyango kunye nezitofu zokugonya. ukuba isasazwe ngakumbi kwihlabathi jikelele..Izibonelelo zokukhenkceza kwefilimu ezibhityileyo zingasetyenziselwa ukuphucula ukuhanjiswa kwemveli okanye ngokudityaniswa namayeza esizukulwana esilandelayo.
MALUNGA NE-TFF PHARMACEUTICALS I-TFF Pharmaceuticals, Inc. yinkampani ye-biopharmaceutical yesigaba seklinikhi esebenzisa iteknoloji yokukhenkcisa enelungelo elilodwa lomenzi wechiza ukuphuhlisa nokuguqula amachiza abe yimixube esebenzayo yomgubo owomileyo ukuphucula ukusebenza, ukhuseleko kunye nokuzinza.Iqonga lenkampani elisebenza ngeendlela ezininzi iThin Film Freezing (TFF) inesicelo esibanzi kwaye ijika naliphi na ichiza, kubandakanya ugonyo, iimolekyuli ezincinci nezinkulu, kunye nebhayoloji, zibe ngumgubo oqaqambileyo owuphefumlayo ekulula ukuwuphefumlela nokufunxwa ngcono, ukuze iyeza likwazi zisiwe.emehlweni, impumlo kunye nolusu lwendawo.I-TFF inabaviwa ababini bezonyango ezinkulu zeklinikhi, i-voriconazole inhalation powder kunye ne-tacrolimus inhalation powder, kwaye iyaqhubeka nokwandisa iphothifoliyo yayo ukuze iguqule ukhathalelo lwempilo yehlabathi ngokusebenzisana noluhlu olubanzi lweenkampani zamachiza, amaziko emfundo kunye namaqabane karhulumente.Iqonga leTFF ligutyungelwe ngamalungelo awodwa omenzi wechiza angaphezu kwe-120 akhutshiweyo okanye asalindelweyo e-US nakwamanye amazwe.Ukufunda ngakumbi malunga ne-TFF Pharmaceuticals kunye neemveliso zayo, nceda undwendwele iwebhusayithi yenkampani ku-https://tffpharma.com.
I-Safe Harbor Esi sikhululo seendaba siqulethe iingxelo ezijonge phambili malunga ne-TFF Pharmaceuticals, Inc., kubandakanywa nokulindela uphuhliso oluqhubekayo lwe-tacrolimus kunye ne-voriconazole yomgubo ophefumlelweyo, iinzuzo zeqonga lenkampani ye-TFF, kunye nezicwangciso zenkampani zokongeza kumgca wemveliso yomviwa okhoyo. .Ezi nkcazo ezijonge phambili zibandakanya imingcipheko eyaziwayo nengaziwa, ukungaqiniseki kunye nezinye izinto ezinokubangela ukuba iziphumo zangempela zihluke ngokwezinto eziphathekayo.Ezi zinto ziquka: (i) umngcipheko wokuba inkampani ayiyi kukwazi ukugqiba ngempumelelo iimvavanyo zeklinikhi okanye ifumane imvume ye-premarket ye-tacrolimus e-inhaled, i-voriconazole powder, okanye nawaphi na abaviwa bayo bomgubo owomileyo, (ii) ukungabikho koluhlu Ichiza elikwiqonga le-TFF lifumene imvume yangaphambili ye-FDA okanye ngenye indlela edwelisa iyeza lentengiso, (iii) inkampani okwangoku ayinasivumelwano okanye ukuqondana nayo nayiphi na inkampani enkulu yoxubo-mayeza ukuphuhlisa iyeza ukuze lifakwe kwiqonga le-TFF, (iv) inkampani ayiyi kuba nako ukungena kwizivumelwano zorhwebo zexesha elide kunye nalo naliphi na iqela lesithathu;kunye (v) neminye imingcipheko echongiweyo kwicandelo “leMicimbi yoMngcipheko” kwiFomu ye-10 yeNgxelo yoNyaka ka-2021 yenkampani – K, efakwe kwi-SEC ngomhla wama-24 kuMatshi, 2022. ukujonga iingxelo.I-TFF Pharmaceuticals ithatha kwaye ayibangeli ngokukodwa nasiphi na isibophelelo sokuhlaziya okanye ukuhlaziywa kweengxelo ezinjalo ukubonisa iimeko ezintsha okanye iimeko ezingalindelekanga, ngaphandle kokuba kufunwa ngumthetho.
TFF Pharmaceuticals Investor Relations Contact: Corey Davis, PhD LifeSci Advisorsscdavis@lifesciadvisors.com 212-915-2577
TFF Pharmaceuticals Media Contact: Gwendolyn SchankerLifeSci Communications(269) 921-3607gschanker@lifescicomms.com


Ixesha lokuposa: Aug-10-2022